Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02273960 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT02273960: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT02273960 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 46 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02273960, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and tolerability of BMS-986004 when administered in subjects with ITP.
Primary Outcome
The primary objective to establish safety was measured by the primary endpoints of AEs and SAEs for both Short term and Long term periods
Interventions
- DRUG BMS-986004 75 mg IV
- DRUG BMS-986004 225 mg IV
- DRUG BMS-986004 675 mg IV
- DRUG BMS-986004 1500 mg IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-11-17 |
| Est. Completion | 2018-01-22 |
| Phase | Phase 1 |
What the finished NCT02273960 record still lists
NCT02273960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 4 interventions - of which BMS-986004 75 mg IV is the first listed.
NCT02273960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02273960 about?
NCT02273960 is a clinical study titled "Study to Evaluate Safety and Efficacy in Adult Subjects With ITP". The purpose of this study is to assess the safety and tolerability of BMS-986004 when administered in subjects with ITP.
What is the current status of trial NCT02273960?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2014-11-17. Estimated completion is 2018-01-22.
What interventions are being tested in trial NCT02273960?
The interventions under investigation include: BMS-986004 75 mg IV (DRUG), BMS-986004 225 mg IV (DRUG), BMS-986004 675 mg IV (DRUG), BMS-986004 1500 mg IV (DRUG).
Who is sponsoring clinical trial NCT02273960?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02273960's enrollment target sits among peer trials
46 1058th of 2000 higher than 935 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI